PLEKHN1 | Pleckstrin homology domain containing, family N member 1 | | | | | | Group enriched |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
TNFRSF18 | Tumor necrosis factor receptor superfamily, member 18 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNFRSF4 | Tumor necrosis factor receptor superfamily, member 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Mixed |
SDF4 | Stromal cell derived factor 4 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CPSF3L | Cleavage and polyadenylation specific factor 3-like | Plasma proteins
| | | | | Expressed in all |
DVL1 | Dishevelled segment polarity protein 1 | Plasma proteins
| | | | | Expressed in all |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
MRPL20 | Mitochondrial ribosomal protein L20 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
ANKRD65 | Ankyrin repeat domain 65 | | | | | | Tissue enhanced |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | | | | Tissue enriched |
CDK11A | Cyclin-dependent kinase 11A | Enzymes
| | | | | Expressed in all |
C1orf222 | Chromosome 1 open reading frame 222 | | | | | | Tissue enhanced |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | | | | Mixed |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
MEGF6 | Multiple EGF-like-domains 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
LRRC47 | Leucine rich repeat containing 47 | | | | | | Expressed in all |
KCNAB2 | Potassium voltage-gated channel, shaker-related subfamily, beta member 2 | Plasma proteins
| | | | | Expressed in all |
ACOT7 | Acyl-CoA thioesterase 7 | Enzymes Mitochondrial proteins
| | | | | Mixed |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
PARK7 | Parkinson protein 7 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Mixed |
DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide | Plasma proteins
| | | | | Expressed in all |
PEX14 | Peroxisomal biogenesis factor 14 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TARDBP | TAR DNA binding protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
EXOSC10 | Exosome component 10 | | | | | | Expressed in all |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PDPN | Podoplanin | Predicted membrane proteins
| | | | | Tissue enhanced |
FHAD1 | Forkhead-associated (FHA) phosphopeptide binding domain 1 | | | | | | Group enriched |
EFHD2 | EF-hand domain family, member D2 | | | | | | Expressed in all |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
SPEN | Spen family transcriptional repressor | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CROCC | Ciliary rootlet coiled-coil, rootletin | | | | | | Expressed in all |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | | | | Tissue enhanced |
PADI1 | Peptidyl arginine deiminase, type I | Enzymes
| | | | | Tissue enriched |